Enibarcimab
恩巴瑞西单抗
Report date: 2026/04/26 20:00:14
First In Class
Base Information
Drug NameEnibarcimab
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory +[4]
CombinationsNo
Global Highest StatusPending (Phase 3 Clinical)
Highest Status in ChinaN/A
Originator CompaniesAdrenomed Ag
China Registration ClassN/A
Develop Information
Active CompaniesN/A
Inactive CompaniesRadboud University Medical CenterAdrenomed AgDr. Med. Mahir Kara As
Active IndicationsN/A
Inactive Indications
Other Information
ATC CodeN/A
Related LinksN/A